To access this element change to forms mode OFF
Grant Award View - GA29923
Understanding the mechanism of action for intravenous immunoglobulin...
GA ID:
GA29923
Agency:
National Health and Medical Research Council (NHMRC)
Approval Date:
25-Oct-2018
Publish Date:
21-Dec-2018
Category:
Medical Research
Grant Term:
1-Jan-2019 to 31-Dec-2021
Value (AUD):
$605,363.40
(GST inclusive where applicable)
One-off/Ad hoc:
No
Aggregate Grant Award:
No
PBS Program Name:
NHMRC 17/18 1.1 Health and Medical Research
Grant Program:
Project
Grant Activity:
Understanding the mechanism of action for intravenous immunoglobulin (IVIG) therapy in spinal cord injury
Purpose:
Traumatic spinal cord injury is an important and costly cause of disability in Australia. The body's immune system plays a key role in the recovery from such injuries, but treatments to effectively target post-traumatic inflammation are lacking. This grant will test a promising new therapy, intravenous immunoglobulin (IVIG), and in particular uncover what cells and molecules are targeted by it so that we can better treat individuals affected by these devastating injuries.
GO ID:
GO Title:
NHMRC Project Grant Scheme
Internal Reference ID:
GNT1163835
Selection Process:
Targeted or Restricted Competitive
Confidentiality - Contract:
Yes
Confidentiality Reason(s) - Contract:
Privacy Act 1988
Intellectual property
Intellectual property
Confidentiality - Outputs:
Yes
Confidentiality Reason(s) - Outputs:
Intellectual property
Grant Recipient Details
Recipient Name:
University of Queensland
Recipient ABN:
63 942 912 684
Grant Recipient Location
Suburb:
St Lucia
Town/City:
St Lucia
Postcode:
4072
State/Territory:
QLD
Country:
AUSTRALIA
Grant Delivery Location
State/Territory:
QLD
Postcode:
Country:
AUSTRALIA